DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr.

2017 年 10 月 18 日 7:00 上午 - 2017 年 10 月 19 日 10:00 下午

1750 Rockville Pike, , Rockville, MD 20852 , USA

Metrics in Patient-Centered Drug Development Conference

Session 6: Resources for Patient Engagement Metrics

Session Chair(s)

Elizabeth  Lincoln, MA

Elizabeth Lincoln, MA

HR Consultant

CCI Consulting, United States

With increasing interest – and investment – in patient centricity, there are corresponding efforts to develop approaches for implementing patient-centric practice and tools for assessing the effectiveness and impact on drug development. Presenters in this session will introduce three tools and the work behind developing them. These tools help organizations navigate the development of their own patient-centric practices, help teams define, quantify, and evaluate the impact of their patient-centric efforts, and provide drug developers with quantifiable measures of various patient-centric activities on areas such as cost, speed, quality, and study participant impact.

Learning Objective :
  • Identify different categories of patient-centric activities and what impact metrics may be specific to those activities
  • Identify ways to measure an organization’s efforts to become more patient-centric and how to reproduce and improve upon patient-centric practice
  • Articulate considerations for developing patient-centric practice appropriate for your organization
  • Speaker(s)

    Elizabeth  Lincoln, MA

    Speaker

    Elizabeth Lincoln, MA

    CCI Consulting, United States

    HR Consultant

    Rebecca  Ashkenazy, MD

    Speaker

    Rebecca Ashkenazy, MD

    Pfizer, Inc., United States

    US Men's & Women's Health Medical Affairs Lead, Pfizer Essential Health

    Mary Jo  Lamberti, PhD, MA

    Speaker

    Mary Jo Lamberti, PhD, MA

    Tufts Center for the Study of Drug Development, United States

    Director of Sponsored Research, Research Associate Professor

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。